• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Final Agenda for the November 15, 2010 Meeting of the Science Board to the FDA

Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814

8:30 a.m.Introductions
Barbara McNeil, M.D., Ph.D., Science Board Chair
8:40 a.m. Commissioner's Report
Margaret Hamburg M.D., Commissioner of Food and Drugs
9:00 a.m.Q&A and Discussion    
9:15 a.m.Science at the FDA
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health, Office of the Chief Scientist, Office of the Commissioner, FDA
9:45 a.m.Q&A and Discussion    
10:05 a.m.BREAK
10:20 a.m.CFSAN evaluation and review of Subcommittee Final Review of Science at CFSAN
Donald Zink, Ph.D., Senior Science Advisor, CFSAN
11:00 a.m.Q&A and Discussion
11:15 a.m.Medical Countermeasures Initiative and Regulatory Science
Luciana Borio, M.D., Senior Advisor for Medicine and Public Health, Office of the Chief Scientist, Office of the Commissioner, FDA
11:30 a.m.  Q&A and Discussion
11:45 a.m.Update: Subcommittee Review of Research at the Center for Drug Evaluation and Research (CDER), Pharmacovigilance Program
Stephen Spielberg, M.D., Ph.D., Subcommittee Co-Chair and Science Board Member
12:10 p.m.Lunch (on your own)
1:10 p.m.Update: Subcommittee Review of Research at the Center for Drug Evaluation and Research (CDER), Pharmacovigilance Program (continued)
Stephen Spielberg, M.D., Ph.D., Subcommittee Co-Chair and Science Board Member
1:25 pmDiscussion: Comparative Effectiveness Research Plan
Vicki Seyfert-Margolis, Ph.D., Senior Advisor for Science, Office of the Chief Scientist, Office of the Commissioner, FDA
2:00 p.m.Q&A and Discussion
2:20 p.m. Comments from the Science Board Chair
Barbara McNeil, M.D., Ph.D., Science Board Chair
2:30 p.m.Adjourn